Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-01-506440
Filing Date
2001-09-19
Accepted
2001-09-19 00:00:00
Documents
8
Period of Report
2001-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR END JUNE 30, 2001 d90604e10-k.txt 10-K 262311
3 CERTIFICATE OF DESIGNATIONS OF NON-VOTING STOCK d90604ex4-2.txt EX-4.2 24487
4 RESTATED P53 AND K-RAS AGREEMENT d90604ex10-36.txt EX-10.36 317746
5 P53 ASSIGNMENT AGREEMENT d90604ex10-37.txt EX-10.37 4703
6 K-RAS ASSIGNMENT AGREEMENT d90604ex10-38.txt EX-10.38 4622
7 REGISTRATION RIGHTS AGREEMENT d90604ex10-39.txt EX-10.39 54807
8 VOTING AGREEMENT d90604ex10-40.txt EX-10.40 21061
9 CONSENT OF ARTHUR ANDERSEN LLP d90604ex23-1.txt EX-23.1 516
  Complete submission text file 0000950134-01-506440.txt   692257
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Filer) CIK: 0001018710 (see all company filings)

EIN.: 742704230 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-21291 | Film No.: 1740204
SIC: 2834 Pharmaceutical Preparations